Ondine Biomedical’s nasal photodisinfection technology is set to be piloted by The Ottowa Hospital (TOH) to reduce infections in spine surgery patients.
The Canada-based life sciences company’s universal, non-antibiotic protocol will be evaluated over a three-month period.
AIM-quoted Ondine's Steriwave™ technology has already been deployed in a number of Canadian hospitals, including Vancouver General and UBC Hospitals, where it has reduced post-operative infection rates for spine surgeries by 78%.
Steriwave fights infections through a process called 'nasal decolonisation' which acts as an effective and low-cost therapy to improves patient outcomes by reducing readmission rates and costs by rapidly eliminating the pathogens they are carrying.
Ondine’s chief executive officer Carolyn Cross commented: "We are very pleased to be working with the spine group at TOH to make our technology available to their patients.
"Following COVID-19, it is more important than ever to reduce patient readmission rates given the large surgery backlogs at all Canadian hospitals.”